EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dosimetric benefits of 1.5 T MR-guided radiotherapy in partial breast treatment

Jiwon Sung, Gyuri Song, Inho Jeong, Jinsook Ha, Yeona Cho, Joongyo Lee, Jihun Kim iD

PLOS One · 12.03.2026 · 21 (3) · e0342973

DOI: 10.1371/journal.pone.0342973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 12.03.2026. Verfasst von Jiwon Sung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Radiotherapy, Image-Guided, Magnetic Resonance Imaging, Breast Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Grant from Gangnam Severance Hospital, Yonsei University College of Medicine, Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the dosimetric benefits of magnetic resonance (MR)-guided radiotherapy (MRgRT) compared to computed tomography (CT)-guided RT for partial breast treatment. First, treatment plan quality was compared between MRgRT with step-and-shoot (S&S) IMRT and CT-guided RT with volumetric-modulated arc therapy (VMAT). Second, the dosimetric benefit of online adaptation in MRgRT was assessed by comparing the initial planned doses with daily MR-defined target geometry to those with planning CT-defined target geometry. Plan quality for MRgRT was comparable to, or slightly lower than, CT-guided RT. The V 95% of the planning target volume (PTV) was lower by 1.72% and 1.94%, respectively, with a lower minimum dose and a higher maximum dose. For the OARs, the dosimetric parameters were generally similar, but for the skin, the D max , D 0.5mL , and D 1mL were slightly higher in MRgRT. Evaluation of the initial planned doses with the daily MR-based target definition resulted in a maximum deviation of 46% for the PTV V 95% , demonstrating uncertainty in CT-based target definition. Although the MRgRT planning quality may be slightly compromised due to the S&S IMRT technique, the dosimetric benefits from online adaptation can be substantial when CT-based target definitions need to be modified based on daily MR imaging guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Image-GuidedMagnetic Resonance ImagingBreast NeoplasmsHumansFemaleRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedRadiotherapy, Intensity-ModulatedRadiometry

Autor:innen und Institutionen

  • Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.

ORCID-Profile: Jihun Kim

Förderung

  • Innovative Research Grant from Gangnam Severance Hospital, Yonsei University College of Medicine
  • Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT

Zitieren

APA

Sung, J., Song, G., Jeong, I., Ha, J., Cho, Y., Lee, J., & Kim, J. (2026). Dosimetric benefits of 1.5 T MR-guided radiotherapy in partial breast treatment. PLOS One, 21(3), e0342973. https://doi.org/10.1371/journal.pone.0342973

Vancouver

Sung J, Song G, Jeong I, Ha J, Cho Y, Lee J, et al. Dosimetric benefits of 1.5 T MR-guided radiotherapy in partial breast treatment. PLOS One. 2026;21(3):e0342973. doi:10.1371/journal.pone.0342973

BibTeX
@article{Sung2026,
  author = {Sung, Jiwon and Song, Gyuri and Jeong, Inho and Ha, Jinsook and Cho, Yeona and Lee, Joongyo and Kim, Jihun},
  title = {Dosimetric benefits of 1.5 T MR-guided radiotherapy in partial breast treatment},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0342973},
  doi = {10.1371/journal.pone.0342973}
}
Kostenlos starten →